Two Sigma Advisers’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,219
| Closed | -$186K | – | 2550 |
|
|
2025
Q1 | $186K | Buy |
+12,219
| New | +$186K | ﹤0.01% | 2155 |
|
|
2024
Q4 | – | Sell |
-10,119
| Closed | -$260K | – | 2538 |
|
|
2024
Q3 | $260K | Sell |
10,119
-52,300
| -84% | -$1.34M | ﹤0.01% | 1970 |
|
|
2024
Q2 | $803K | Buy |
62,419
+42,300
| +210% | +$544K | ﹤0.01% | 1666 |
|
|
2024
Q1 | $461K | Sell |
20,119
-15,000
| -43% | -$344K | ﹤0.01% | 1906 |
|
|
2023
Q4 | $919K | Buy |
35,119
+12,456
| +55% | +$326K | ﹤0.01% | 1678 |
|
|
2023
Q3 | $637K | Buy |
22,663
+13,913
| +159% | +$391K | ﹤0.01% | 1704 |
|
|
2023
Q2 | $266K | Buy |
8,750
+6,200
| +243% | +$188K | ﹤0.01% | 2018 |
|
|
2023
Q1 | $47.9K | Sell |
2,550
-820
| -24% | -$15.4K | ﹤0.01% | 2451 |
|
|
2022
Q4 | $34.4K | Buy |
+3,370
| New | +$34.4K | ﹤0.01% | 2391 |
|
|
2021
Q4 | – | Sell |
-1,140
| Closed | -$155K | – | 2809 |
|
|
2021
Q3 | $155K | Sell |
1,140
-1,170
| -51% | -$159K | ﹤0.01% | 2289 |
|
|
2021
Q2 | $339K | Buy |
+2,310
| New | +$339K | ﹤0.01% | 2100 |
|